CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
In urgent need of financial assistance? Find out where to locate immediate financial help to address your needs.
23,157 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
The Commerce Department imposed export controls on Anthropic’s latest AI models after a probe described as a narrow j...
A rare cross‑party proposal would remove the payroll tax cap to boost funding for Social Security. If enacted, the pl...
A $900,000 inherited 401(k) faces the SECURE Act’s 10-year rule, with recent IRS guidance adding complexity for heirs...
Geopolitical tensions with Iran push mortgage rates higher this week, lifting monthly costs for home buyers as bond m...
Public Masterpiece launches PMT Chain, a dedicated Layer 1 for authenticating real-world assets. The move redefines t...
A wave of selling hit AI-related shares after a blog post framed AI gains as 'science fiction.' Behavioral finance ex...
Magic Eden confirms a strategic pivot, winding down Ethereum, Polygon, and Bitcoin NFT marketplaces to double down on...
Global markets tumble as President Trump’s policy shifts on Iran fuel uncertainty. Investors scramble to gauge exit p...
Oil has moved markets again, with crude flirting with triple digits and energy stocks lighting up in response. This g...
Bitcoin hovers near a critical zone as traders weigh whether a floor is forming or a deeper pullback lies ahead. ETF ...
Condo financing faces new insurance hurdles as lenders adjust rules; affordability hinges on policy shifts and region...